Form 4: Amgen SVP & CCO Reports Stock Disposal for Tax Obligations

Nancy A. Grygiel, SVP & CCO of Amgen, reports the disposal of 113 shares of common stock to cover tax obligations related to dividend equivalents.

Summary

• Nancy A. Grygiel, a Senior Vice President and Chief Commercial Officer at Amgen Inc., filed a Form 4 on April 30, 2025.
• The filing reports a transaction where 113 shares of Amgen common stock were disposed of at a price of $288.56 per share.
• This disposal was to cover tax obligations.
• Following the transaction, Grygiel directly owns 8,101 shares of Amgen common stock.
• Grygiel also indirectly owns 102.9274 shares through the company's 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a routine transaction. It doesn't convey any particularly positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. This transaction is related to tax obligations, which is a common reason for stock disposals by executives.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares for tax purposes.

Key Dates

Keywords

Form 4, Amgen, Stock Disposal, Insider Trading, Beneficial Ownership, AMGN, Grygiel, CCO, SVP, Dividend Equivalents, 401(k)